Search Results - "Begum, Nusrat J"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    The effect of ligand amount, affinity and internalization on PSMA-targeted imaging and therapy: A simulation study using a PBPK model by Begum, Nusrat J., Glatting, Gerhard, Wester, Hans-Jürgen, Eiber, Matthias, Beer, Ambros J., Kletting, Peter

    Published in Scientific reports (27-12-2019)
    “…The aim of this work was to investigate the effect of ligand amount, affinity and internalization of prostate-specific membrane antigen (PSMA)-specific ligands…”
    Get full text
    Journal Article
  2. 2

    Important pharmacokinetic parameters for individualization of 177 Lu-PSMA therapy: A global sensitivity analysis for a physiologically-based pharmacokinetic model by Hardiansyah, Deni, Kletting, Peter, Begum, Nusrat J, Eiber, Matthias, Beer, Ambros J, Pawiro, Supriyanto A, Glatting, Gerhard

    Published in Medical physics (Lancaster) (01-02-2021)
    “…The knowledge of the contribution of anatomical and physiological parameters to interindividual pharmacokinetic differences could potentially be used to…”
    Get full text
    Journal Article
  3. 3

    The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for 177 Lu-Labeled PSMA Peptides by Begum, Nusrat J, Thieme, Anne, Eberhardt, Nina, Tauber, Robert, D'Alessandria, Calogero, Beer, Ambros J, Glatting, Gerhard, Eiber, Matthias, Kletting, Peter

    Published in Journal of Nuclear Medicine (01-06-2018)
    “…The aim of this work was to simulate the effect of prostate-specific membrane antigen (PSMA)-positive total tumor volume (TTV) on the biologically effective…”
    Get full text
    Journal Article
  4. 4

    Important pharmacokinetic parameters for individualization of 177Lu‐PSMA therapy: A global sensitivity analysis for a physiologically‐based pharmacokinetic model by Hardiansyah, Deni, Kletting, Peter, Begum, Nusrat J., Eiber, Matthias, Beer, Ambros J., Pawiro, Supriyanto A., Glatting, Gerhard

    Published in Medical physics (Lancaster) (01-02-2021)
    “…Purpose The knowledge of the contribution of anatomical and physiological parameters to interindividual pharmacokinetic differences could potentially be used…”
    Get full text
    Journal Article
  5. 5

    The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for ^sup 177^Lu-Labeled PSMA Peptides by Begum, Nusrat J, Thieme, Anne, Eberhardt, Nina, Tauber, Robert, D’Alessandria, Calogero, Beer, Ambros J, Glatting, Gerhard, Eiber, Matthias, Kletting, Peter

    Published in The Journal of nuclear medicine (1978) (01-06-2018)
    “…The aim of this work was to simulate the effect of prostate-specific membrane antigen (PSMA)–positive total tumor volume (TTV) on the biologically effective…”
    Get full text
    Journal Article
  6. 6

    The Effect of Total Tumor Volume on the Biologically Effective Dose to Tumor and Kidneys for 177Lu-Labeled PSMA Peptides by Begum, Nusrat J, Thieme, Anne, Eberhardt, Nina, Tauber, Robert, D'Alessandria, Calogero, Beer, Ambros J, Glatting, Gerhard, Eiber, Matthias, Kletting, Peter

    Published in The Journal of nuclear medicine (1978) (01-06-2018)
    “…The aim of this work was to simulate the effect of prostate-specific membrane antigen (PSMA)-positive total tumor volume (TTV) on the biologically effective…”
    Get full text
    Journal Article